Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1196)
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$236.24
Total Value
$47.25K
Shares Held After
200
% of Holdings
100.0%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
2,239
Price
$26.78
Total Value
$59.96K
Shares Held After
150,260
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
760
Price
$578.12
Total Value
$439.37K
Shares Held After
18,876
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,929
Price
$577.13
Total Value
$1.11M
Shares Held After
19,636
% of Holdings
8.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,221
Price
$576.21
Total Value
$703.55K
Shares Held After
21,565
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
809
Price
$575.24
Total Value
$465.37K
Shares Held After
22,786
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
281
Price
$574.13
Total Value
$161.33K
Shares Held After
23,595
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
440
Price
$572.70
Total Value
$251.99K
Shares Held After
23,876
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
860
Price
$571.93
Total Value
$491.86K
Shares Held After
24,316
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
700
Price
$570.92
Total Value
$399.64K
Shares Held After
25,176
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
760
Price
$569.79
Total Value
$433.04K
Shares Held After
25,876
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,040
Price
$568.54
Total Value
$591.28K
Shares Held After
26,636
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
520
Price
$567.36
Total Value
$295.03K
Shares Held After
27,676
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
240
Price
$566.37
Total Value
$135.93K
Shares Held After
28,196
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
280
Price
$564.02
Total Value
$157.93K
Shares Held After
28,436
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
135
Price
$561.21
Total Value
$75.76K
Shares Held After
28,716
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
25
Price
$559.58
Total Value
$13.99K
Shares Held After
28,851
% of Holdings
0.1%
KalVista Pharmaceuticals, Inc. (KALV)
Sweeny Nicole — Chief Commercial Officer
Shares
1,489
Price
$26.78
Total Value
$39.87K
Shares Held After
59,291
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,020
Price
$577.97
Total Value
$589.53K
Shares Held After
40,513
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,620
Price
$577.03
Total Value
$934.80K
Shares Held After
41,533
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$574.57
Total Value
$321.76K
Shares Held After
44,653
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$572.66
Total Value
$343.60K
Shares Held After
45,213
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
717
Price
$571.77
Total Value
$409.96K
Shares Held After
45,813
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
683
Price
$570.84
Total Value
$389.89K
Shares Held After
46,530
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
642
Price
$569.69
Total Value
$365.74K
Shares Held After
47,213
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
958
Price
$568.63
Total Value
$544.75K
Shares Held After
47,855
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$567.42
Total Value
$295.06K
Shares Held After
48,813
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$566.36
Total Value
$181.23K
Shares Held After
49,333
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$564.02
Total Value
$135.37K
Shares Held After
49,653
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$562.16
Total Value
$22.49K
Shares Held After
49,893
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
35
Price
$560.74
Total Value
$19.63K
Shares Held After
49,933
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
45
Price
$560.52
Total Value
$25.22K
Shares Held After
49,968
% of Holdings
0.1%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
65,000
Price
$35.69
Total Value
$2.32M
Shares Held After
24,353
% of Holdings
72.7%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
25,582
Price
$26.02
Total Value
$665.52K
Shares Held After
350,987
% of Holdings
6.8%
Outlook Therapeutics, Inc. (OTLK)
Haddadin Yezan Munther — Director
Shares
34,000
Price
$0.44
Total Value
$14.96K
Shares Held After
37,167
% of Holdings
91.5%
Outlook Therapeutics, Inc. (OTLK)
THURMAN RANDY H — Director
Shares
5,000
Price
$0.43
Total Value
$2.15K
Shares Held After
5,593
% of Holdings
89.4%
Outlook Therapeutics, Inc. (OTLK)
HILZINGER KURT J — Director
Shares
400,000
Price
$0.44
Total Value
$176.52K
Shares Held After
423,655
% of Holdings
94.4%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
67,950
Price
$0.47
Total Value
$31.94K
Shares Held After
763,685
% of Holdings
8.2%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$60.38
Total Value
$1.51M
Shares Held After
1,048,095
% of Holdings
2.3%
Rein Therapeutics, Inc. (RNTX)
VON RICKENBACH JOSEF H — Director
Shares
15,950
Price
$1.05
Total Value
$16.71K
Shares Held After
34,824
% of Holdings
45.8%
Ainos, Inc. (AIMD)
TSAI CHUN-JUNG — Director
Shares
1,082
Price
$1.55
Total Value
$1.68K
Shares Held After
685,917
% of Holdings
0.2%
HCW Biologics Inc. (HCWB)
Byam Rebecca — Chief Financial Officer
Shares
14,235
Price
$1.41
Total Value
$20.00K
Shares Held After
57,245
% of Holdings
24.9%
HCW Biologics Inc. (HCWB)
GARRETT SCOTT T — Director
Shares
177,936
Price
$1.41
Total Value
$250.00K
Shares Held After
203,441
% of Holdings
87.5%
HCW Biologics Inc. (HCWB)
Wong Hing C — Director
Shares
113,879
Price
$1.41
Total Value
$160.00K
Shares Held After
615,790
% of Holdings
18.5%
Jazz Pharmaceuticals plc (JAZZ)
McSharry Heather Ann — Director
Shares
2,000
Price
$241.00
Total Value
$482.00K
Shares Held After
18,449
% of Holdings
9.8%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
519
Price
$35.00
Total Value
$18.16K
Shares Held After
25,249
% of Holdings
2.0%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
9,315
Price
$33.88
Total Value
$315.59K
Shares Held After
25,768
% of Holdings
26.6%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
32,963
Price
$33.22
Total Value
$1.10M
Shares Held After
35,083
% of Holdings
48.4%
OMEROS CORP (OMER)
Cable Thomas J. — Director
Shares
7,500
Price
$11.61
Total Value
$87.04K
Shares Held After
35,067
% of Holdings
17.6%
Jazz Pharmaceuticals plc (JAZZ)
Winningham Rick E — Director
Shares
2,741
Price
$241.57
Total Value
$662.14K
Shares Held After
9,567
% of Holdings
22.3%
Showing 251–300 of 1196 transactions (page 6 of 24)